Abciximab Reopro

Previous
Next


CLASS: Antiplatelet agent, Platelet Aggregation Inhibitor 

Indications: UA/NSTMI patients undergoing planned or emergent PCI

Dosage: 0.25 mg/kg IV then 0.125 mcg/kg/min IV infusion 

Packaging: Injection - 2mg/ml 5ml vials

 

© Matt Dillard 2012